Literature DB >> 19271288

Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells.

Jordane Jasniewski1, Catherine Cailliez-Grimal, Isabelle Chevalot, Jean-Bernard Millière, Anne-Marie Revol-Junelles.   

Abstract

Two purified class IIa carnobacteriocins Cbn BM1 and Cbn B2, from Carnobacterium maltaromaticum CP5, were evaluated for antimicrobial activity against pathogenic, spoilage and lactic acid bacteria. Then, the presence of a synergistic mode of action of these two carnobacteriocins on Listeria sp., Enterococcus sp. and Carnobacterium sp. was investigated. A synergistic mode of action between Cbn BM1 and Cbn B2 on sensitive target bacteria was demonstrated using the FIC index method. Combinations of carnobacteriocins enhanced their antibacterial activities and MICs were significantly reduced, between 2- and 15-fold, by the addition of the second bacteriocin. To improve the safety of the bacteriocins as biopreservative agents, the cytotoxicity of the combination of theses two bacteriocins was determined on Caco-2 cell line. However, these two peptides used alone or in combination, at concentration 100-fold higher than those required for antimicrobial activity, were not cytotoxic. This suggests that the two carnobacteriocins produced by C. maltaromaticum CP5 could be potential natural agents for food preservation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19271288     DOI: 10.1016/j.fct.2009.01.025

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  8 in total

Review 1.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

2.  Characterization, Toxicity, and Optimization for the Growth and Production of Bacteriocin-like Substances by Lactobacillus curvatus.

Authors:  Graciele Daiana Funck; Juliana de Lima Marques; Guilherme da Silva Dannenberg; Claudio Eduardo Dos Santos Cruxen; Carla Pohl Sehn; Marina Prigol; Márcia Rósula Poetini Silva; Wladimir Padilha da Silva; Ângela Maria Fiorentini
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

Review 3.  Using bacterial genomes and essential genes for the development of new antibiotics.

Authors:  Francisco R Fields; Shaun W Lee; Michael J McConnell
Journal:  Biochem Pharmacol       Date:  2016-12-08       Impact factor: 5.858

4.  Development of Class IIa Bacteriocins as Therapeutic Agents.

Authors:  Christopher T Lohans; John C Vederas
Journal:  Int J Microbiol       Date:  2011-11-30

Review 5.  Bacteriocins in the Era of Antibiotic Resistance: Rising to the Challenge.

Authors:  Gratiela Gradisteanu Pircalabioru; Laura Ioana Popa; Luminita Marutescu; Irina Gheorghe; Marcela Popa; Ilda Czobor Barbu; Rodica Cristescu; Mariana-Carmen Chifiriuc
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

6.  Garvicin KS, a Broad-Spectrum Bacteriocin Protects Zebrafish Larvae against Lactococcus garvieae Infection.

Authors:  Saurabh Dubey; Dzung B Diep; Øystein Evensen; Hetron M Munang'andu
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

7.  Enhanced salt-tolerance of Bacillus subtilis glutaminase by fusing self-assembling amphipathic peptides at its N-terminus.

Authors:  Song Liu; Shengqi Rao; Xiao Chen; Jianghua Li
Journal:  Front Bioeng Biotechnol       Date:  2022-09-07

8.  Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations.

Authors:  Samira Soltani; Riadh Hammami; Paul D Cotter; Sylvie Rebuffat; Laila Ben Said; Hélène Gaudreau; François Bédard; Eric Biron; Djamel Drider; Ismail Fliss
Journal:  FEMS Microbiol Rev       Date:  2021-01-08       Impact factor: 16.408

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.